ADPT · CIK 0001478320 · operating
Adaptive Biotechnologies Corp (ADPT) is a biological products, (no diagnostic substances) company incorporated in WA, listed on the Nasdaq. With a market capitalization of $2.5 billion, Adaptive Biotechnologies Corp is a mid-cap company. The stock currently trades at $16.12, up 0.62% today, with a 52-week range of $6.25–$20.76.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.39 | $-0.39 | +63.9% | |
| 2024 | $-1.08 | $-1.08 | +30.8% | |
| 2023 | $-1.56 | $-1.56 | -11.4% | |
| 2022 | $-1.40 | $-1.40 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-076902 | SEC ↗ |
| 2024-12-31 | 2025-03-03 | 0000950170-25-030913 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0000950170-24-023095 | SEC ↗ |
| 2022-12-31 | 2023-02-14 | 0000950170-23-002792 | SEC ↗ |
| 2021-12-31 | 2022-02-15 | 0001564590-22-005228 | SEC ↗ |
| 2020-12-31 | 2021-02-24 | 0001564590-21-008124 | SEC ↗ |
| 2019-12-31 | 2020-02-26 | 0001564590-20-006830 | SEC ↗ |